Transplant Medicine Featured News Feb. 12, 2022 How to optimize referral timing for severe liver disease Timing referral of these patients to discuss transplant or other options is challenging. Disease status can turn quickly, and it's important to not refer too early or late. Dec. 28, 2021 Right-fit care for patients with severe lung disease: From clinical trials to transplant A lung transplant surgeon discusses Mayo Clinic's collaboration with local physicians to determine the best treatment for each patient, including transplant, clinical trials or other therapies, or transplant prehabilitation. Nov. 20, 2021 Liver transplantation for colorectal liver metastases at Mayo Clinic in Jacksonville, Florida Mayo Clinic in Jacksonville, Florida, is one of only a few centers in the U.S. offering liver transplant as a treatment option for highly selected patients with colorectal liver metastases. May 08, 2021 When it's time to consider organ, tissue or eye donation in trauma care A Mayo Clinic Office of Decedent Affairs specialist and LifeSource coordinator answers questions trauma centers may have about organ, tissue or eye donations from their transferred trauma patients. Latest Videos See All Heart Transplant Program at Mayo Clinic Mayo Clinic’s Heart Transplant programs is the largest integrated transplant center with three locations across the nation. Our heart transplant experts discuss our program and the benefits of collaboration when referring a patient to our teams. Mayo Clinic’s Kidney Transplant Metabolic Program As obesity has grown to affect 40% of the U.S. population and 60% of patients seeking kidney transplant, body mass index (BMI) — a traditional transplant criterion — has become a barrier. Aleksandra Kukla, M.D., a transplant nephrologist and Tayyab Diwan, M.D., kidney transplant surgeon discuss this unique program. Optimal Time to Refer for Kidney Transplant Evaluation Carrie A. Schinstock, M.D., transplant nephrologist at Mayo Clinic, discusses the benefits of referring patients with kidney failure for a transplant evaluation sooner rather than later. Clinical Trials See All A Study to Evaluate the Safety and Effectiveness of MGTA-145 Combined with Plerixafor for Transplantation of Stem Cells in Recipients with Hematological MalignanciesRochester, Minn.A Study of Patients Treated for Chronic Granulomatous Disease Since 1995Rochester, Minn.BT – L-CsA – 301 – SLT: A Phase III, Prospective, Multicenter, Randomized, Controlled Clinical Trial to Demonstrate the Efficacy and Safety of Liposomal Cyclosporine A (L-CsA) Inhalation Solution Delivered via the PARI Investigational eFlow® Device plus Standard of Care versus Standard of Care Alone in the Treatment of Chronic Lung Allograft Syndrome / Bronchiolitis Obliterans Syndrome in Patients post Single Lung Transplantation Jacksonville, Fla. Calculators These models are to be used by medical professionals. More News 1 Lifestyle changes can be critical for kidney transplant patients' long-term survival 2 Mayo Clinic's campus in Rochester, Minnesota, offers new liver transplant programs 3 Regenerative technology uncovers new discoveries in liver disease 4 Mayo Clinic in Florida: First hospital in the world to use a new heart pump as bridge to transplant 5 Order is everything: New procedure for heart-liver transplant averts rejection risk Medical Professionals Transplant Medicine